secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2023-12-06T23:59:59+00:00
Accession:  0001628908-23-000183
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health prices $350M convertible notes at 3.5% due 2029 to repay term loan
--------------------------------------------------------------------------------

- $350M aggregate principal, 3.5% coupon, semiannual interest, matures Dec 1, 2029.
- Initial conversion price ~$38.00/share, a 42.5% premium over Dec 5 closing price.
- Underwriters granted a 30-day option to purchase up to an additional $52.5M of notes.
- Net proceeds plus available liquidity will prepay outstanding term loan facility.
- Notes convertible into cash, shares, or combination at Evolent's election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000183/0001628908-23-000183-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000183/evh-20231205.htm
  HTML page:      https://secwatch.observer/filing/0001628908-23-000183

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer